Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Formulation (Cream, Gel, Spray, Patch, and Others), Type (Prescription Pain Relief and Over-the-Counter Pain Relief), and Distribution Channel (Pharmacies & Drug Stores, E-Commerce, and Retail & Grocery Stores): Global Opportunity Analysis and Industry Forecast,2027
Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Formulation (Cream, Gel, Spray, Patch, and Others), Type (Prescription Pain Relief and Over-the-Counter Pain Relief), and Distribution Channel (Pharmacies & Drug Stores, E-Commerce, and Retail & Grocery Stores): Global Opportunity Analysis and Industry Forecast,2027
The topical pain relief market refers to the market for products that are applied externally to alleviate pain and discomfort. These products typically come in the form of creams, gels, sprays, patches, or ointments and they are designed to provide localized relief for various types of pain, such as muscle aches, joint pain, arthritis, strains, and sprains. The topical pain relief market has experienced significant growth in recent years due to several factors. These include the increasing prevalence of chronic pain conditions, such as arthritis and back pain, the aging population, and the growing demand for non-invasive and drug-free pain management options. Additionally, the rise in sports-related injuries and the growing adoption of topical pain relief products among athletes have contributed to market expansion. Moreover, there has been a growing awareness and acceptance of topical pain relief products among healthcare professionals and consumers which further leads to market growth. As more research is conducted and evidence supporting their effectiveness accumulates, healthcare providers are more likely to recommend these products to their patients. Additionally, consumers are increasingly open to exploring alternative pain relief options, driving the demand for topical solutions. However, the factors such as irritated skin, pungent smell of the medication may hamper the market growth. Topical Pain Relief Market is likely to grow at a rate of 6.1% CAGR by 2027.
Topical Pain Relief marketby Therapeutic
Non-opioids
Opioids
Topical Pain Relief market by Formulation
Cream
Gel
Spray
Patch
Topical Pain Relief market by Distribution Channel
Pharmacies & drug stores
E-Commerce
Retail & grocery stores
Topical Pain Relief Market by Geography
North America
Europe
Asia Pacific
Rest of the World
Based on therapeutic, the market is bifurcated into Non-opioids and Opioids. The Non-opioids segment expected to have the highest share in the market. This is due to its preferable usage over the opioid drugs for treatment of mild to moderate pain. Moreover, owing to minimum side effects as compared to opioids and no substance abuse, non-opioids are the preferred choice for the treatment of pain.
On the bases of formulation, the market has been divided into Cream, Gel, Spray and Patch. Cream-based formulation segment has held a maximum share in the market. The maximum share is due to increased availability of these products with a high success rate and minimum side effects.
Key players in the topical pain relief market include pharmaceutical companies, consumer healthcare companies, and specialized manufacturers. Some of the well-known brands in this market include Bengay, Icy Hot, Voltaren, Biofreeze, and Salonpas, among others. These companies offer a wide range of products with different active ingredients and formulations to target specific types of pain.
In terms of distribution channel, topical pain relief products are available over-the-counter (OTC) in pharmacies, drugstores, supermarkets, and online retail platforms. Some products may also require a prescription and are sold through healthcare providers and pharmacies.
The topical pain relief market is highly competitive, and companies are continuously innovating to develop new formulations and improve the effectiveness of their products. Some of the advancements in this market include the incorporation of natural ingredients, the use of transdermal drug delivery systems, and the development of products with longer-lasting effects.
It's important to note that as an AI, my knowledge cutoff is in September 2021. Therefore, there may have been further developments or changes in the topical pain relief market since then
The major leading companies of the topical pain relief market are Advacare Pharma, Glaxosmithkline Plc (Gsk), Johnson & Johnson, Nestlé S.A, Novartis Ag, Pfizer Inc, Reckitt Benckiser Group Plc, Sanofi, Sun Pharmaceutical Industries Ltd, and Topical Biomedics, Inc.
It's worth noting that market trends and dynamics can change over time. For the most up-to-date information on the current state of the market, it is advisable to refer to recent market research reports, industry publications, and engage with experts in the pharmaceutical sector. An exclusive analysis of all key geographical regions is included in the report which determines the potential opportunities in these regions.
Detailed information about the attributes which are generating growth in the topical pain relief market in the forecast period.
An exact estimation of the topical pain relief market share and its contribution to the parent market is provided in the report.
Further profiles of leading competitors and their dynamic strategies are also covered in thestudy.
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Therapeutic: Market Size & Analysis
5.1. Overview
5.2. Non-opioids
5.3. Opioids
6. Formulation: Market Size & Analysis
6.1. Overview
6.2. Cream
6.3. Gel
6.4. Spray
6.5. Patch
7. Distribution Channel: Market Size & Analysis
7.1. Overview
7.2. Pharmacies & drug stores
7.3. E-Commerce
7.4. Retail & grocery stores
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. Advacare Pharma
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. Glaxosmithkline Plc (Gsk)
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Johnson & Johnson
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Nestlé S.A
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Novartis Ag
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Pfizer Inc
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Reckitt Benckiser Group Plc
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Sanofi
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Sun Pharmaceutical Industries Ltd
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Topical Biomedics, Inc
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
TABLE 1. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR NON-OPIOIDS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR OPIOIDS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR CREAM, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR GEL, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR SPRAY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR PATCH, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR PHARMACIES & DRUG STORES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR E-COMMERCE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR RETAIL & GROCERY STORES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. NORTH AMERICA TOPICAL PAIN RELIEF MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 14. NORTH AMERICA TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 15. NORTH AMERICA TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 16. NORTH AMERICA TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 17. U.S TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 18. U.S TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 19. U.S TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 20. CANADA TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 21. CANADA TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 22. CANADA TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 23. EUROPE TOPICAL PAIN RELIEF MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 24. EUROPE TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 25. EUROPE TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 26. EUROPE TOPICAL PAIN RELIEF MARKET VALUE, DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 27. GERMANY TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 28. GERMANY TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 29. GERMANY TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 30. U.K TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 31. U.K TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 32. U.K TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 33. FRANCE TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 34. FRANCE TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 35. FRANCE TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 36. ITALY TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 37. ITALY TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 38. ITALY TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 39. SPAIN TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 40. SPAIN TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 41. SPAIN TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 42. ROE TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 43. ROE TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 44. ROE TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 45. ASIA PACIFC TOPICAL PAIN RELIEF MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 46. ASIA PACIFC TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 47. ASIA PACIFC TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 48. ASIA PACIFC TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 49. CHINA TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 50. CHINA TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 51. CHINA TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 52. INDIA TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 53. INDIA TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 54. INDIA TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 55. JAPAN TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 56. JAPAN TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 57. JAPAN TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 58. REST OF APAC TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 59. REST OF APAC TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 60. REST OF APAC TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 61. REST OF WORLD TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 62. REST OF WORLD TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 63. REST OF WORLD TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 64. ADVACARE PHARMA: FINANCIALS
TABLE 65. ADVACARE PHARMA: PRODUCTS & SERVICES
TABLE 66. ADVACARE PHARMA: RECENT DEVELOPMENTS
TABLE 67. GLAXOSMITHKLINE PLC (GSK): FINANCIALS
TABLE 68. GLAXOSMITHKLINE PLC (GSK): PRODUCTS & SERVICES
TABLE 69. GLAXOSMITHKLINE PLC (GSK): RECENT DEVELOPMENTS
TABLE 70. JOHNSON & JOHNSON: FINANCIALS
TABLE 71. JOHNSON & JOHNSON: PRODUCTS & SERVICES
TABLE 72. JOHNSON & JOHNSON: RECENT DEVELOPMENTS
TABLE 73. NESTLÉ S.A: FINANCIALS
TABLE 74. NESTLÉ S.A: PRODUCTS & SERVICES
TABLE 75. NESTLÉ S.A: RECENT DEVELOPMENTS
TABLE 76. NOVARTIS AG: FINANCIALS
TABLE 77. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 78. NOVARTIS AG: RECENT DEVELOPMENTS
TABLE 79. PFIZER INC: FINANCIALS
TABLE 80. PFIZER INC: PRODUCTS & SERVICES
TABLE 81. PFIZER INC: RECENT DEVELOPMENTS
TABLE 82. RECKITT BENCKISER GROUP PLC: FINANCIALS
TABLE 83. RECKITT BENCKISER GROUP PLC: PRODUCTS & SERVICES
TABLE 84. RECKITT BENCKISER GROUP PLC: RECENT DEVELOPMENTS
TABLE 85. SANOFI: FINANCIALS
TABLE 86. SANOFI: PRODUCTS & SERVICES
TABLE 87. SANOFI: RECENT DEVELOPMENTS
TABLE 88. SUN PHARMACEUTICAL INDUSTRIES LTD: FINANCIALS
TABLE 89. SUN PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS & SERVICES
TABLE 90. SUN PHARMACEUTICAL INDUSTRIES LTD: RECENT DEVELOPMENTS
TABLE 91. TOPICAL BIOMEDICS, INC: FINANCIALS
TABLE 92. TOPICAL BIOMEDICS, INC: PRODUCTS & SERVICES
TABLE 93. TOPICAL BIOMEDICS, INC: RECENT DEVELOPMENTS
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|